TITLE

High incidence of chronic graft-versus-host disease after myeloablative allogeneic stem cell transplantation for chronic lymphocytic leukemia in Sweden: graft-versus-leukemia effect protects against relapse

AUTHOR(S)
Machaczka, Maciej; Johansson, Jan-Erik; Remberger, Mats; Hallböök, Helene; Lazarevic, Vladimir Lj; Wahlin, Björn Engelbrekt; Omar, Hamdy; Wahlin, Anders; Juliusson, Gunnar; Kimby, Eva; Hägglund, Hans
PUB. DATE
December 2013
SOURCE
Medical Oncology;Dec2013, Vol. 30 Issue 4, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
92576439

 

Related Articles

  • Adoptive Immunotherapy in Chimeras with Donor Lymphocytes. Kolb, Hans-Jochem; Schmid, Christoph; Chen, Xiao; Woiciechowski, Anja; Roskrow, Marie; Weber, Martin; Guenther, Wolfgang; Ledderose, Georg; Schleuning, Michael // Acta Haematologica;Oct2003, Vol. 110 Issue 2/3, p110 

    Allogeneic stem cell transplantation has a well-defined indication in the treatment of hematological malignancies. The beneficial immune effect of allogeneic marrow transplantation has long been known, but only recently have methods been developed to separate the graft-versus-leukemia (GVL)...

  • Implication of Early Lymphocyte Recovery after Allogeneic Hematopoietic Stem Cell Transplantation in Children with Leukemia. Dong Kyun Han; Hee Jo Baek; So Yeon Kim; Tai Ju Hwang; Hoon Kook // Yonsei Medical Journal;Jan2013, Vol. 54 Issue 1, p62 

    Purpose: The repopulating lymphocytes after allogeneic hematopoietic stem cell transplantation have an important role not only on the prevention of serious infections in the early transplantation period, but also on the killing of residual leukemic cells by graft-versus-leukemia effect. The aim...

  • Cyclophosphamide/pentostatin/rituximab.  // Reactions Weekly;May2014, Vol. 1501 Issue 1, p16 

    An abstract of the article "Donor lymphocyte infusion followed by pentostatin, cyclophosphamide and rituximab therapy is effective for relapsed chronic lymphocytic leukemia after allogeneic stem cell transplant" by Watanabe M and colleagues is presented.

  • Outcome of allogeneic stem cell transplantation for B cell chronic lymphocytic leukemia. Pavletic, Z S; Arrowsmith, E R; Bierman, P J; Goodman, S A; Vose, J M; Tarantolo, S R; Stein, R S; Bociek, G; Greer, J P; Wu, C D; Kollath, J P; Weisenburger, D D; Kessinger, A; Wolff, S N; Armitage, J O; Bishop, M R // Bone Marrow Transplantation;4/1/2000, Vol. 25 Issue 7, p717 

    The objective of this study was to describe the outcome of allogeneic stem cell transplantation (alloSCT) in a series of patients with B cell chronic lymphocytic leukemia (B-CLL). Twenty-three B-CLL patients were transplanted between 1988 and 1997 using stem cells from a related (n = 20) or an...

  • Influence of ultraviolet-B irradiation on engraftment, graft-versus-host disease and graft-versus-leukemia effect in a rat model for allogeneic bone marrow transplantation. Gowing, H.; Braakman, E.; Hagenbeek, A.; Lawler, M.; McCann, S.R.; Pamphilon, D.H.; Martens, A.C.M. // Bone Marrow Transplantation;4/15/98, Vol. 21 Issue 8, p801 

    Ultraviolet-B (UVB) irradiation is known to inhibit lymphocyte activity and consequently to reduce the incidence of graft-versus-host disease (GVHD) in experimental models for allogeneic bone marrow transplantation (BMT). GVHD is frequently associated with morbidity and mortality, but also with...

  • The graft-versus-leukemia effect of nonmyeloablative stem cell allografts may not be sufficient to cure chronic myelogenous leukemia. Sloand, E; Childs, R W; Solomon, S; Greene, A; Young, N S; Barrett, A J // Bone Marrow Transplantation;Nov2003, Vol. 32 Issue 9, p897 

    Summary:We treated 12 patients with chronic myelogenous leukemia (CML) with a low-intensity preparative regimen followed by allogeneic stem cell transplantation in an attempt to confer a curative graft-versus-leukemia (GVL) effect with minimum morbidity. Seven patients in first chronic phase...

  • Treatment of relapsing leukemia after allogeneic blood stem cell transplantation by using dose-reduced conditioning followed by donor blood stem cells and GM-CSF. Platzbecker, Uwe; Thiede, Christian; Freiberg-Richter, Jens; Helwig, Anett; Mohr, Brigitte; Prange, Gabriele; Füssel, Monika; Kühler, Thomas; Ehninger, Gerhard; Bornhäuser, Martin; Platzbecker, U; Thiede, C; Freiberg-Richter, J; Helwig, A; Mohr, B; Prange, G; Füssel, M; Köhler, T; Ehninger, G; Bornhäuser, M // Annals of Hematology;Mar2001, Vol. 80 Issue 3, p144 

    Ten patients with high-risk acute myeloid leukemia (AML), chronic myeloid leukemia (CML), and myelodysplastic syndrome (MDS) relapsing early (< 1 year, n = 8) or late (> or = 1 year, n = 2) after allogeneic transplantation were treated with cytoreductive chemotherapy followed by unmanipulated...

  • Allogeneic haematopoietic stem cell transplantation: current status and future outlook. Aschan, Johan // British Medical Bulletin;Jan2006, Vol. 77/78 Issue 1, p23 

    Allogeneic haematopoietic stem cell transplantation (allo-SCT) is an established treatment of haematological malignancies and other immunohaematopoietic disorders. The use of unrelated donors and cord blood (CB) grafts has increased the possibilities of finding a donor, and results are...

  • A frameshift polymorphism in P2X5 elicits an allogeneic cytotoxic T lymphocyte response associated with remission of chronic myeloid leukemia. de Rijke, Björn; van Horssen-Zoetbrood, Agnes; Beekman, Jeffrey M.; Otterud, Britt; Maas, Frans; Woestenenk, Rob; Kester, Michel; Leppert, Mark; Schattenberg, Anton V.; Witte, Theo de; van de Wiel-van Kemenade, Elly; Dolstra, Harry // Journal of Clinical Investigation;Dec2005, Vol. 115 Issue 12, p3506 

    Minor histocompatibility antigens (mHAgs) constitute the targets of the graft-versus-leukemia response after HLA-identical allogeneic stem cell transplantation. Here, we have used genetic linkage analysis to identify a novel mHAg, designated lymphoid-restricted histocompatibility antigen-1...

  • Combined immunoradiotherapy induces long-term remission of CNS relapse of peripheral, diffuse, large-cell lymphoma after allogeneic stem cell transplantation: Case study. Lotze, Christian; Sch�ler, Frank; Kr�ger, William H.; Hirt, Carsten; Kirsch, Michael; Vogelgesang, Silke; Schmidt, Christian A.; D�lken, Gotifried // Neuro-Oncology;Oct2005, Vol. 7 Issue 4, p508 

    Relapse of peripheral non-Hodgkin's lymphoma (NHL) in the central nervous system commonly has a poor prognosis. Graft-versus-leukemia effects (GvL) contribute substantially to eradication of hematological malignancies after allogeneic stem cell transplantation. Few data are available describing...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics